Trial Profile
Phase II study of gemcitabine + cisplatin in patients with unresectable advanced gallbladder cancer. Multicenter study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Aug 2017
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Gemcitabine (Primary)
- Indications Gallbladder cancer
- Focus Therapeutic Use
- 01 Jul 2017 Results published in the Cancer Chemotherapy and Pharmacology
- 01 Jul 2017 Status changed from active, no longer recruiting to completed according to results published in the Cancer Chemotherapy and Pharmacology.
- 16 Nov 2012 New trial record